Chlorothalonil


Curated chemical-phenotype interactions from CTD
GO IDGO nameInteraction typeReference
GO:0006006 Glucose metabolic process Affects phenotype PMID:33246813
GO:0006090 Pyruvate metabolic process Affects phenotype PMID:33246813
GO:0006631 Fatty acid metabolic process Affects phenotype PMID:33246813
GO:0006641 Triglyceride metabolic process Affects phenotype PMID:33246813
GO:0006915 Apoptotic process Increases phenotype PMID:34549778
GO:0006974 Cellular response to dna damage stimulus Increases phenotype PMID:19591892
GO:0007224 Smoothened signaling pathway Decreases phenotype PMID:31652400
GO:0008284 Positive regulation of cell population proliferation Decreases phenotype PMID:28426875
GO:0008285 Negative regulation of cell population proliferation Increases phenotype PMID:29555536
GO:0009437 Carnitine metabolic process Affects phenotype PMID:33246813
GO:0043065 Positive regulation of apoptotic process Increases phenotype PMID:30586609
GO:0045617 Negative regulation of keratinocyte differentiation Increases phenotype PMID:32289622
GO:0046621 Negative regulation of organ growth Increases phenotype PMID:30586609
GO:0048160 Primary follicle stage Increases phenotype PMID:30586609
GO:0051548 Negative regulation of keratinocyte migration Increases phenotype PMID:32289622
GO:0051881 Regulation of mitochondrial membrane potential Affects phenotype PMID:34549778
GO:0072537 Fibroblast activation Increases phenotype PMID:32289622
GO:0072593 Reactive oxygen species metabolic process Affects phenotype PMID:34549778
GO:1905071 Tight junction disassembly Increases phenotype PMID:34549778
GO:2000355 Negative regulation of ovarian follicle development Increases phenotype PMID:30586609
GO:2000865 Negative regulation of estradiol secretion Increases phenotype PMID:30586609
GO:2000871 Negative regulation of progesterone secretion Increases phenotype PMID:30586609
DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.